Report cover image

Pharmacovigilance Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Sep 14, 2024
Length 143 Pages
SKU # PROD19315814

Description

Pharmacovigilance Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global pharmacovigilance market is expected to grow at a CAGR of around 8.6% during 2025-2034. This report on global pharmacovigilance market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global pharmacovigilance market by segmenting the market based on product, service provider, type, process flow, therapeutic area, end use, and region. Also, detailed profiles of companies operating in the pharmacovigilance market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increased Lifestyle Diseases
• Growing Initiatives by Manufacturers

Market Challenges

• Lack of Skilled Professional

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Product

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

Market by Service Provider

• In-house
• Contract Outsourcing

Market by Type

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Market by Process Flow

• Case Data Management
Case Logging
Case Data Analysis
Medical Reviewing & Reporting
• Signal Detection
Adverse Event Logging
Adverse Event Analysis
Adverse Event Review & Reporting
• Risk Management System
Risk Evaluation System
Risk Mitigation System

Market by Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Other Areas

Market by End-Use

• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

143 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Pharmacovigilance Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Pharmacovigilance Market Analysis
4.1. Market Portraiture
4.2. Market Product
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Pharmacovigilance Market by Product
5.1. Introduction
5.2. Pre-clinical
5.3. Phase I
5.4. Phase II
5.5. Phase III
5.6. Phase IV
6. Global Pharmacovigilance Market by Service Provider
6.1. Introduction
6.2. In-house
6.3. Contract Outsourcing
7. Global Pharmacovigilance Market by Type
7.1. Introduction
7.2. Spontaneous Reporting
7.3. Intensified ADR Reporting
7.4. Targeted Spontaneous Reporting
7.5. Cohort Event Monitoring
7.6. EHR Mining
8. Global Pharmacovigilance Market by Process Flow
8.1. Introduction
8.2. Case Data Management
8.2.1. Case Logging
8.2.2. Case Data Analysis
8.2.3. Medical Reviewing & Reporting
8.3. Signal Detection
8.3.1. Adverse Event Logging
8.3.2. Adverse Event Analysis
8.3.3. Adverse Event Review & Reporting
8.4. Risk Management System
8.4.1. Risk Evaluation System
8.4.2. Risk Mitigation System
9. Global Pharmacovigilance Market by Therapeutic Area
9.1. Introduction
9.2. Oncology
9.3. Neurology
9.4. Cardiology
9.5. Respiratory Systems
9.6. Other Areas
10. Global Pharmacovigilance Market by End-Use
10.1. Introduction
10.2. Pharmaceuticals
10.3. Biotechnology Companies
10.4. Medical Device Manufacturers
10.5. Other End Uses
11. Global Pharmacovigilance Market by Region
11.1. Introduction
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Netherlands
11.2.8. Rest of the Europe
11.3. North America
11.3.1. United States
11.3.2. Canada
11.4. Asia Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. South Korea
11.4.5. Australia
11.4.6. Indonesia
11.4.7. Rest of the Asia Pacific
11.5. Latin America
11.5.1. Mexico
11.5.2. Brazil
11.5.3. Argentina
11.5.4. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. Turkey
11.6.3. Iran
11.6.4. United Arab Emirates
11.6.5. Rest of Middle East & Africa
12. SWOT Analysis
13. Porter’s Five Forces
14. Market Value Chain Analysis
15. Competitive Landscape
15.1. Competitive Scenario
15.2. Company Profiles
15.2.1. Accenture plc
15.2.2. ArisGlobal LLC
15.2.3. BioClinica Inc.
15.2.4. Capgemini
15.2.5. ClinChoice (formerly FMD K&L)
15.2.6. Cognizant
15.2.7. ICON plc.
15.2.8. International Business Machines Corporation
15.2.9. IQVIA Inc.
15.2.10. ITClinical
15.2.11. Parexel International Corporation
15.2.12. United BioSource LLC
15.2.13. Wipro Limited
List of Figures
Figure 1: Global Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 2: Global Pharmacovigilance Market by Product, 2024
Figure 3: Global Pharmacovigilance Market by Service Provider, 2024
Figure 4: Global Pharmacovigilance Market by Type, 2024
Figure 5: Global Pharmacovigilance Market by Process Flow, 2024
Figure 6: Global Pharmacovigilance Market by Therapeutic Area, 2024
Figure 7: Global Pharmacovigilance Market by End-Use, 2024
Figure 8: Global Pharmacovigilance Market by Region, 2024
Figure 9: Global Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 10: Global Pharmacovigilance Market by Product (in %), 2024 & 2034
Figure 11: Global Pre-clinical Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 12: Global Pre-clinical Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 13: Global Phase I Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 14: Global Phase I Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 15: Global Phase II Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 16: Global Phase II Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 17: Global Phase III Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 18: Global Phase III Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 19: Global Phase IV Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 20: Global Phase IV Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 21: Global Pharmacovigilance Market by Service Provider (in %), 2024 & 2034
Figure 22: Global In-house Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 23: Global In-house Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 24: Global Contract Outsourcing Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 25: Global Contract Outsourcing Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 26: Global Pharmacovigilance Market by Type (in %), 2024 & 2034
Figure 27: Global Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 28: Global Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 29: Global Intensified ADR Reporting Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 30: Global Intensified ADR Reporting Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 31: Global Targeted Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 32: Global Targeted Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 33: Global Cohort Event Monitoring Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 34: Global Cohort Event Monitoring Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 35: Global EHR Mining Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 36: Global EHR Mining Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 37: Global Pharmacovigilance Market by Process Flow (in %), 2024 & 2034
Figure 38: Global Case Data Management Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 39: Global Case Data Management Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 40: Case Logging Data Management Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 41: Case Data Analysis Data Management Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 42: Medical Reviewing & Reporting Case Data Management Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 43: Global Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 44: Global Signal Detection Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 45: Adverse Event Logging Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 46: Adverse Event Analysis Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 47: Adverse Event Review & Reporting Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 48: Global Risk Management System Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 49: Global Risk Management System Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 50: Evaluation System Risk Management System Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 51: Mitigation System Risk Management System Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 52: Global Pharmacovigilance Market by Therapeutic Area (in %), 2024 & 2034
Figure 53: Global Oncology Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 54: Global Oncology Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 55: Global Neurology Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 56: Global Neurology Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 57: Global Cardiology Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 58: Global Cardiology Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 59: Global Respiratory Systems Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 60: Global Respiratory Systems Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 61: Global Other Areas Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 62: Global Other Areas Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 63: Global Pharmacovigilance Market by End-Use (in %), 2024 & 2034
Figure 64: Global Pharmaceuticals Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 65: Global Pharmaceuticals Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 66: Global Biotechnology Companies Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 67: Global Biotechnology Companies Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 68: Global Medical Device Manufacturers Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 69: Global Medical Device Manufacturers Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 70: Global Other End Uses Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 71: Global Other End Uses Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 72: Global Pharmacovigilance Market by Region (in %), 2024 & 2034
Figure 73: Europe Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 74: Europe Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 75: Europe Pharmacovigilance Market by Country (in %), 2024 & 2034
Figure 76: Germany Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 77: United Kingdom Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 78: France Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 79: Italy Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 80: Spain Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 81: Russia Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 82: Netherlands Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 83: North America Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 84: North America Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 85: North America Pharmacovigilance Market by Country (in %), 2024 & 2034
Figure 86: United States Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 87: Canada Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 88: Asia Pacific Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 89: Asia Pacific Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 90: Asia Pacific Pharmacovigilance Market by Country (in %), 2024 & 2034
Figure 91: China Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 92: Japan Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 93: India Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 94: South Korea Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 95: Australia Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 96: Indonesia Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 97: Latin America Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 98: Latin America Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 99: Latin America Pharmacovigilance Market by Country (in %), 2024 & 2034
Figure 100: Mexico Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 101: Brazil Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 102: Argentina Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 103: Middle East & Africa Pharmacovigilance Market (in US$ Million), 2020-2024
Figure 104: Middle East & Africa Pharmacovigilance Market (in US$ Million), 2025-2034
Figure 105: Middle East & Africa Pharmacovigilance Market by Country (in %), 2024 & 2034
Figure 106: Saudi Arabia Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 107: Turkey Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 108: Iran Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 109: UAE Pharmacovigilance Market (in US$ Million), 2020-2034
Figure 110: Market Value Chain
List of Tables
Table 1: Global Pharmacovigilance Market Portraiture
Table 2: Global Pharmacovigilance Market by Product (in US$ Million), 2024 & 2034
Table 3: Global Pharmacovigilance Market by Service Provider (in US$ Million), 2024 & 2034
Table 4: Global Pharmacovigilance Market by Type (in US$ Million), 2024 & 2034
Table 5: Global Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
Table 6: Case Data Management Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
Table 7: Signal Detection Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
Table 8: Risk Management System Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
Table 9: Global Pharmacovigilance Market by Therapeutic Area (in US$ Million), 2024 & 2034
Table 10: Global Pharmacovigilance Market by End-Use (in US$ Million), 2024 & 2034
Table 11: Global Pharmacovigilance Market by Region (in US$ Million), 2024 & 2034
Table 12: Europe Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
Table 13: North America Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
Table 14: Asia Pacific Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
Table 15: Latin America Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
Table 16: Middle East & Africa Pharmacovigilance Market by Country (in US$ Million),
2024 & 2034
Table 17: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us